Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol.
D000293:Adolescent; D000328:Adult; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005989:Glycerides / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D006937:Hypercholesterolemia / Q000139:chemically induced*; D006951:Hyperlipoproteinemias / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000009:adverse effects*; D010672:Phenytoin / Q000009:adverse effects*
D005989:Glycerides; D010672:Phenytoin; D006854:Hydrocortisone; D010634:Phenobarbital